Cargando…
Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data
BACKGROUND: During carcinogenesis, tumors develop multiple mechanisms for evading the immune response, including upregulation of Fas ligand (FasL/CD95L) expression. Expression of FasL may help to maintain tumor cells in a state of immune privilege by inducing apoptosis of anti-tumor immune effector...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373622/ https://www.ncbi.nlm.nih.gov/pubmed/16457714 http://dx.doi.org/10.1186/1477-3163-5-5 |